Follow-up with (18)FDG-PET-CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: A prospective study
van Loon, Judith × Grutters, Janneke P. C Wanders, Rinus Boersma, Liesbeth Oellers, Michel Dingemans, Anne-Marie Bootsma, Gerben Geraedts, Wiel Pitz, Cordula Simons, Jean Fatah, Sakar Abdul Snoep, Gabriel Hochstenbag, Monique Lambin, Philippe De Ruysscher, Dirk #
European Journal of Cancer vol:45 issue:4 pages:588-595
Background: Follow-up of patients treated with curative intent for non-small cell lung cancer (NSCLC) with X-ray or CT-scans is of unproven value. Furthermore, most patients with progressive disease present with symptoms outside of follow-up visits. Because the accuracy of (18)FDG-PET-CT is superior to CT, we hypothesised that FDG-PET-CT scans 3 months post-treatment could lead to early detection of progressive disease (PD) amenable for radical treatment.